Intercept Pharmaceuticals, Inc.

FULLER & THALER ASSET MANAGEMENT, INC.

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

193,940

Value ($000)

3,596

Weight

0.0%

2021 Q4 - 2023 Q3 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	3,596	0.0%	193,940	9/30/2023
2023 Q2	8/14/2023	2,228	0.0%	201,460	6/30/2023
2022 Q2	8/12/2022	2,283	0.0%	165,310	6/30/2022
2022 Q1	5/13/2022	2,672	0.0%	164,210	3/31/2022
2021 Q4	2/9/2022	2,662	0.0%	163,385	12/31/2021